Literature DB >> 32986175

Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery.

Shannan M Dickinson1, Caitlin A McIntyre2, Juliana B Schilsky3, Kate A Harrington3, Scott R Gerst3, Jessica R Flynn4, Mithat Gonen4, Marinela Capanu4, Winston Wong5, Sharon Lawrence2, Peter J Allen2,6, Eileen M O'Reilly5, William R Jarnagin2, Michael I D'Angelica2, Vinod P Balachandran2, Jeffrey A Drebin2, T Peter Kingham2, Amber L Simpson2,7, Richard K Do3.   

Abstract

PURPOSE: To evaluate the associations between computed tomography (CT) imaging features extracted from the structured American Pancreatic Association (APA)/Society of Abdominal Radiology (SAR) template and overall survival in patients with resected pancreatic ductal adenocarcinoma (PDAC).
METHODS: This retrospective analysis included consecutive patients with PDAC who consented to genomic tumor testing and underwent preoperative imaging and curative intent surgical resection from December 2006 to July 2017. Two radiologists assessed preoperative CT imaging using the APA/SAR PDAC-reporting template. Univariable associations between overall survival and imaging variables were evaluated using Cox proportional hazards regression.
RESULTS: The study included 168 patients (66 years ± 11; 91 women). 126/168 patients (75%) received upfront surgical resection whereas 42/168 (25%) received neoadjuvant therapy prior to surgical resection. In the entire cohort, features associated with decreased overall survival were tumor arterial contact of any kind (hazard ratio (HR) 1.89, 95% CI 1.13-3.14, p = 0.020), tumor contact with the common hepatic artery (HR 2.33, 95% CI 1.35-4.04, p = 0.009), and portal vein deformity (HR 3.22, 95% CI 1.63-6.37, p = 0.003). In the upfront surgical group, larger tumor size was associated with decreased overall survival (HR 2.30, 95% CI 1.19-4.42, p = 0.013). In the neoadjuvant therapy group, the presence of venous collaterals was the only feature associated with decreased overall survival (HR 2.28, 95% CI 1.04-4.99, p = 0.042).
CONCLUSION: The application of the APA/SAR pancreatic adenocarcinoma reporting template may identify predictors of survival that can aid in preoperative stratification of patients.

Entities:  

Keywords:  Carcinoma; Neoadjuvant therapy; Neoplasm staging; Pancreatic carcinoma; Pancreatic ductal; Survival analysis; Tomography; X-ray computed

Mesh:

Year:  2020        PMID: 32986175      PMCID: PMC8004545          DOI: 10.1007/s00261-020-02726-w

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  22 in total

1.  Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.

Authors:  Stephanie T Chang; R Brooke Jeffrey; Bhavik N Patel; Michael A DiMaio; Jarrett Rosenberg; Juergen K Willmann; Eric W Olcott
Journal:  Radiology       Date:  2016-07-20       Impact factor: 11.105

2.  Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.

Authors:  Hop S Tran Cao; Alpana Balachandran; Huamin Wang; Graciela M Nogueras-González; Christina E Bailey; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Gauri Varadhachary; Christopher H Crane; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

3.  Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer.

Authors:  Geoffrey M Kozak; Jeffrey D Epstein; Sandeep P Deshmukh; Benjamin B Scott; Scott W Keith; Harish Lavu; Charles J Yeo; Jordan M Winter
Journal:  J Gastrointest Surg       Date:  2017-11-14       Impact factor: 3.452

4.  Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.

Authors:  Akimasa Nakao; Akiyuki Kanzaki; Tsutomu Fujii; Yasuhiro Kodera; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shigeo Nakamura; Satoshi Morita; Shin Takeda
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

5.  Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.

Authors:  Christophe Cassinotto; Jaron Chong; George Zogopoulos; Caroline Reinhold; Laurence Chiche; Jean-Pierre Lafourcade; Adeline Cuggia; Eric Terrebonne; Anthony Dohan; Benoît Gallix
Journal:  Eur J Radiol       Date:  2017-02-22       Impact factor: 3.528

6.  Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.

Authors:  Nils D Arvold; Andrzej Niemierko; Harvey J Mamon; Carlos Fernandez-del Castillo; Theodore S Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

7.  Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.

Authors:  Jin Hee Kim; Seong Ho Park; Eun Sil Yu; Myung-Hwan Kim; Jihun Kim; Jae Ho Byun; Seung Soo Lee; Hye Jeon Hwang; Jae-Yeon Hwang; Sang Soo Lee; Moon-Gyu Lee
Journal:  Radiology       Date:  2010-08-09       Impact factor: 11.105

8.  Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.

Authors:  Seung Baek Hong; Seung Soo Lee; Jin Hee Kim; Hyoung Jung Kim; Jae Ho Byun; Seung Mo Hong; Ki-Byung Song; Song Cheol Kim
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

9.  Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma.

Authors:  Min Young Park; Sang Hyun Shin; Ki Byung Song; DaeWook Hwang; Jae Hoon Lee; Young-Joo Lee; Song Cheol Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

10.  Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.

Authors:  Diego A S Toesca; R Brooke Jeffrey; Rie von Eyben; Erqi L Pollom; Peter D Poullos; George A Poultsides; George A Fisher; Brendan C Visser; Albert C Koong; Daniel T Chang
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

View more
  2 in total

1.  Prognostic Imaging Biomarkers for Pancreatic Ductal Adenocarcinoma Extracted from Structured Radiologist Reports.

Authors:  Nikita Consul
Journal:  Radiol Imaging Cancer       Date:  2020-11-27

2.  Radiomics for CT Assessment of Vascular Contact in Pancreatic Adenocarcinoma.

Authors:  Richard K G Do; Avinash Kambadakone
Journal:  Radiology       Date:  2021-09-07       Impact factor: 29.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.